These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 19597130)
1. Right brain: my first tPA. Robbins MS Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130 [No Abstract] [Full Text] [Related]
2. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study]. Di Pasquale G Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744 [No Abstract] [Full Text] [Related]
3. Tissue plasminogen activator use in a patient with acute ischemic stroke coexisting with meningioma. Hsieh HC; Chen CH Clin Neurol Neurosurg; 2009 Jul; 111(6):562-3. PubMed ID: 19200644 [No Abstract] [Full Text] [Related]
5. Thrombolytic therapy with alteplase for ischaemic stroke. Drug Ther Bull; 2009 Feb; 47(2):14-8. PubMed ID: 19193701 [TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator for acute ischemic stroke: a New York city emergency medicine perspective. Chan YF; Kwiatkowski TG; Rella JG; Rennie WP; Kwon RK; Silverman RA J Emerg Med; 2005 Nov; 29(4):405-8. PubMed ID: 16243196 [TBL] [Abstract][Full Text] [Related]
7. The smoking-thrombolysis paradox and acute ischemic stroke. Fisher M Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964 [No Abstract] [Full Text] [Related]
8. Clinical applicability and the perfusion-diffusion mismatch theory: not yet a perfect match. Harrer JU Neurology; 2010 Sep; 75(12):1034-5. PubMed ID: 20739642 [No Abstract] [Full Text] [Related]
9. Tissue plasminogen activator for acute ischemic stroke. Caplan LR N Engl J Med; 1999 Oct; 341(16):1240-1. PubMed ID: 10523162 [No Abstract] [Full Text] [Related]
10. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients. Whitcomb DS Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750 [No Abstract] [Full Text] [Related]
11. Questions about authorisation of alteplase for ischaemic stroke. Shinton R Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265 [No Abstract] [Full Text] [Related]
12. [Possible thrombolytic treatment of cerebral ischemia of over 3 hours after the first symptom]. Cztonkowska A; Kobayashi A Neurol Neurochir Pol; 2009; 43(4):400. PubMed ID: 19795553 [No Abstract] [Full Text] [Related]
13. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues. Liang BA; Lew R; Zivin JA Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160 [TBL] [Abstract][Full Text] [Related]
14. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little. Hoffman JR Med J Aust; 2003 Oct; 179(7):333-4. PubMed ID: 14503891 [No Abstract] [Full Text] [Related]
15. Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients. Saver JL; Barsan WG Neurology; 2010 Apr; 74(17):1336-7. PubMed ID: 20335563 [No Abstract] [Full Text] [Related]
16. Evidence and doubt in the translation of research into care. Lancet; 2014 Aug; 384(9944):638. PubMed ID: 25152260 [No Abstract] [Full Text] [Related]
17. Litigation regarding tPA and stroke. Pilcher CA Ann Emerg Med; 2009 Mar; 53(3):404; author reply 404-5. PubMed ID: 19231673 [No Abstract] [Full Text] [Related]